Update on 2‐year outcomes of the TOMS™ transobturator male sling for the treatment of male stress urinary incontinence
- 12 October 2014
- journal article
- research article
- Published by Wiley in Neurourology and Urodynamics
- Vol. 35 (1) , 44-47
Abstract
Aims: To update the 2‐year outcomes of the TOMS™ transobturator male sling for treating post‐prostatectomy urinary incontinence (pRP‐UI) in a group of patients previously evaluated at 1 year.Methods: We prospectively followed 40 patients with pRP‐UI before and 6, 12, and 24 months after implantation of the TOMS™ transobturator male sling. Urinary symptoms were evaluated using the following questionnaires: USP, ICIQ, UCLA‐PCI (urinary bother domain), PGI‐I, and daily pad use. Success was defined as patients wearing no or only one security pad. We also report on any other surgical procedures for treating persistent incontinence during the follow‐up period.Results: Of 40 patients included in the 1‐year follow‐up, seven required additional surgical treatment. In the remaining patients (n = 33), significant improvement (P < 0.001) compared to baseline was seen, and a subsequent tendency (non‐significant) toward impairment was noted throughout the three postoperative follow‐ups for the ICIQ (14.4 ± 4.4 [baseline], 7.6 ± 5.7 [6 months], 8.1 ± 5.6 [12 months], 8.9 ± 5.5 [24 months]), USP‐stress urinary (6.7 ± 2.2, 2.8 ± 2.4, 2.8 ± 2.4, 3.2 ± 2.8), ULCA‐PCI‐urinary bother (10.0 ± 12.5, 66.0 ± 33.0, 64.0 ± 31.5, 62.0 ± 30.7) scores, and pad use (2.5 ± 1.2, 0.7 ± 1.1, 0.8 ± 1.2, 0.9 ± 1.2). Significant impairment in postoperative PGI‐I (6.2 ± 0.9, 6.1 ± 0.9, 5.8 ± 1.1, P = 0.028) and USP‐overactive bladder symptoms scores (5.4 ± 3.6 [6 months] vs. 6.6 ± 3.7 [24 months], P = 0.046) were noted. A total of 18 (54.5%), 17 (51.5%), and 15 (45.5%) patients wore no postoperative pad, respectively.Conclusion: Approximately half of the patients continue to wear no pad 2 years after TOMS™ transobturator male sling implantation. However, a tendency toward impaired continence, possibly associated with overactive bladder symptoms, was noted. Neurourol. Urodynam. 35:44–47, 2016.Keywords
This publication has 13 references indexed in Scilit:
- The two-year outcome of the I-Stop TOMS™ transobturator sling in the treatment of male stress urinary incontinence in a single centre and prediction of outcomeProgrès en Urologie, 2013
- Therapeutic Durability of the Male Transobturator Sling: Midterm Patient Reported OutcomesJournal of Urology, 2012
- Urodynamic Parameters After Retrourethral Transobturator Male Sling and Their Influence on OutcomeUrology, 2011
- Contemporary Management of Postprostatectomy IncontinenceEuropean Urology, 2011
- Patient-perceived outcomes of the AdVance sling up to 40 months post procedureNeurourology and Urodynamics, 2011
- Mid‐term results for the retroluminar transobturator sling suspension for stress urinary incontinence after prostatectomyBJU International, 2010
- The AdVance Transobturator Male Sling for Postprostatectomy Incontinence: Clinical Results of a Prospective Evaluation after a Minimum Follow-up of 6 MonthsEuropean Urology, 2009
- Comprehensive Evaluation of Bladder and Urethral Dysfunction Symptoms: Development and Psychometric Validation of the Urinary Symptom Profile (USP) QuestionnaireUrology, 2008
- ICIQ: A brief and robust measure for evaluating the symptoms and impact of urinary incontinenceNeurourology and Urodynamics, 2004
- The UCLA Prostate Cancer IndexMedical Care, 1998